Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
600.84B
Market cap600.84B
Price-Earnings ratio
28.63
Price-Earnings ratio28.63
Dividend yield
2.12%
Dividend yield2.12%
Average volume
7.93M
Average volume7.93M
High today
$253.55
High today$253.55
Low today
$246.43
Low today$246.43
Open price
$248.90
Open price$248.90
Volume
11.10M
Volume11.10M
52 Week high
$269.43
52 Week high$269.43
52 Week low
$162.30
52 Week low$162.30

Stock Snapshot

With a market cap of 600.84B, Johnson & Johnson(JNJ) trades at $251.40. The stock has a price-to-earnings ratio of 28.63 and currently yields dividends of 2.12%.

As of 2026-07-16, Johnson & Johnson(JNJ) stock has fluctuated between $246.43 and $253.55. The current price stands at $251.40, placing the stock +2.0% above today's low and -0.8% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 11.1M, compared to an average daily volume of 7.93M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $162.30.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $162.30.

JNJ News

Simply Wall St 8h
Johnson & Johnson Crosses $100 Billion As DePuy Synthes Buys Spine Tech

Johnson & Johnson (NYSE:JNJ) has surpassed the $100b annual revenue mark for the first time in its 140 year history, supported by strong second quarter results....

Johnson & Johnson Crosses $100 Billion As DePuy Synthes Buys Spine Tech
TipRanks 9h
Johnson & Johnson upgraded to Buy at Freedom Broker after strong quarter

As previously reported, Freedom Broker analyst Ilya Zubkov upgraded Johnson & Johnson to Buy from Hold with a price target of $280, up from $230, after “a stron...

TipRanks 9h
Johnson & Johnson upgraded to Buy from Hold at Freedom Broker

Freedom Broker upgraded Johnson & Johnson to Buy from Hold with a $280 price target Published first on TheFly – the ultimate source for real-time, market-movin...

Analyst ratings

73%

of 26 ratings
Buy
73.1%
Hold
23.1%
Sell
3.8%

More JNJ News

TipRanks 12h
Johnson & Johnson price target raised to $305 from $265 at Scotiabank

Scotiabank raised the firm’s price target on Johnson & Johnson to $305 from $265 and keeps an Outperform rating on the shares. The firm is raising its price tar...

Nasdaq 12h
Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026?

Key Points Johnson & Johnson maintains a diversified presence across innovative medicine and medical technology, generating significant cash flow. Eli Lilly i...

Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026?
BBC 12h
Everton A-Z: Jagielka, Johnson and Jeffers - BBC

...

Everton A-Z: Jagielka, Johnson and Jeffers - BBC
TipRanks 1d
Johnson & Johnson Earnings Call Signals Confident Growth

Johnson & Johnson ((JNJ)) has held its Q2 earnings call. Read on for the main highlights of the call. TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has enter...

Nasdaq 1d
Stock Market Today, July 15: Markets Rise on Cooler Inflation and Strong Earnings Start

The Nasdaq Composite (NASDAQINDEX:^IXIC) rose 0.62% to 26,269 as technology buyers focused on artificial intelligence (AI) infrastructure, the S&P 500 (SNPINDEX...

Stock Market Today, July 15: Markets Rise on Cooler Inflation and Strong Earnings Start
TipRanks 1d
JNJ: Strong Innovative Medicine Drives Guidance Raise but Mixed MedTech Keeps Risk/Reward Balanced, Supporting Hold Rating

In a report released today, Rick Wise from Stifel Nicolaus maintained a Hold rating on Johnson & Johnson, with a price target of $260.00. TipRanks has entered...

24/7 Wall St. 1d
Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price

Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price By Vandita Jadeja Published Jul 15, 1:29PM EDT Quick Read JNJ earns a B...

Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.